RecruitingNot ApplicableNCT05797545

Comparison of Ultrasound and Breast MRI for Breast Cancer Detection

Comparison of Ultrasound and Breast MRI for Breast Cancer Detection Among Women With Dense Breasts and a Personal History of Breast Cancer


Sponsor

Samsung Medical Center

Enrollment

1,756 participants

Start Date

Apr 23, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this randomized clinical trial is to compare diagnostic results of secondary breast cancer surveillance using breast ultrasound abbreviated MRI and full protocol MRI.


Eligibility

Sex: FEMALEMin Age: 20 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This trial compares breast ultrasound and breast MRI in women with dense breasts and a prior breast cancer history to see which method is better at detecting new or recurrent cancer. **You may be eligible if...** - You are a woman aged 20–75 with a history of breast cancer (stage 0–3) - You have dense breasts (category C or D) on your most recent mammogram - You have not had a breast imaging test in the past 6 months - You agree to annual mammography, ultrasound, and MRI **You may NOT be eligible if...** - You currently have symptoms suggesting active breast cancer or recurrence - You have had regional or distant metastatic recurrence - You have had both breasts completely removed - You are receiving chemotherapy for another cancer - You are pregnant or breastfeeding - You have severe kidney problems, claustrophobia, a metal implant incompatible with MRI, or a history of severe contrast reactions Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTBreast MRI for Breast Cancer Detection

Comparison of diagnostic results of abbreviated breast MRI and full protocol MRI for secondary breast cancer surveillance


Locations(3)

Inje University Busan Paik Hospital

Busan, BusanJin-Gu, South Korea

Samsung Medical center

Seoul, Gangnam-gu, South Korea

Soon Chun Hyang University Hospital Seoul

Seoul, Yongsan-Gu, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05797545


Related Trials